Selected article for: "acellular pertussis vaccine and pertussis vaccine"

Author: Hughes, Michelle M; Englund, Janet A; Kuypers, Jane; Tielsch, James M; Khatry, Subarna K; Shrestha, Laxman; LeClerq, Steven C; Steinhoff, Mark; Katz, Joanne
Title: Population-Based Pertussis Incidence and Risk Factors in Infants Less Than 6 Months in Nepal
  • Document date: 2017_3_1
  • ID: 0pymqxwq_40
    Snippet: We observed a low incidence of pertussis in infants in a whole cell vaccine environment. Pertussis cases were generally milder than expected compared with traditional pertussis clinical definitions. These data support clinicians considering pertussis in their differential diagnosis of infants with mild respiratory symptoms. Policymakers in Nepal will need to weigh the benefit of an additional prenatal pertussis vaccine or a switch to acellular pr.....
    Document: We observed a low incidence of pertussis in infants in a whole cell vaccine environment. Pertussis cases were generally milder than expected compared with traditional pertussis clinical definitions. These data support clinicians considering pertussis in their differential diagnosis of infants with mild respiratory symptoms. Policymakers in Nepal will need to weigh the benefit of an additional prenatal pertussis vaccine or a switch to acellular primary pertussis vaccine with the low burden of pertussis in infants less than 6 months. Our study demonstrated that mid-nasal swabs were able to detect pertussis using a sensitive multitarget PCR. The less invasive mid-nasal nasal swab is an attractive alternative for pertussis nasal swab collection, and further research is needed to compare this collection site with nasopharyngeal swabs. In the future, this method may enhance population-based surveillance efforts.

    Search related documents:
    Co phrase search for related documents
    • attractive alternative and clinical definition: 1
    • attractive alternative and nasal swab collection: 1
    • attractive alternative and nasopharyngeal swab: 1, 2, 3, 4, 5, 6, 7
    • cell vaccine and differential diagnosis: 1, 2
    • cell vaccine and low burden: 1
    • cell vaccine and low incidence: 1, 2
    • clinical definition and low incidence: 1
    • clinical definition and nasopharyngeal swab: 1
    • collection site and low burden: 1
    • collection site and nasopharyngeal swab: 1
    • differential diagnosis and nasopharyngeal swab: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • low burden and nasopharyngeal swab: 1, 2, 3, 4
    • low incidence and mild respiratory symptom: 1
    • low incidence and nasopharyngeal swab: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • mid nasal swab and nasal swab collection: 1
    • mid nasal swab and nasopharyngeal swab: 1, 2, 3, 4, 5, 6, 7, 8
    • mild respiratory symptom and nasal swab collection: 1